SCHEMBL23277944

SCHEMBL23277944

CC(C)[C@]1(C)Cc2cc(NC(O)c3cnn4cccnc34)c(N3CCOCC3)cc2O1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19045318 1.00 IRAK4 (0.72) IRAK4
SCHEMBL19045673 0.94 IRAK4 (0.73) IRAK4
SCHEMBL19045849 0.92 IRAK4 (0.70) IRAK4
SCHEMBL19045646 0.88 IRAK4 (0.74) IRAK4
SCHEMBL19046072 0.87 IRAK4 (0.73) IRAK4
SCHEMBL23278035 0.87 IRAK4 (0.71) IRAK4
SCHEMBL19045667 0.87 IRAK4 (0.75) IRAK4
SCHEMBL19046158 0.86 IRAK4 (0.75) IRAK4
SCHEMBL23277887 0.86 IRAK4 (0.73) IRAK4
SCHEMBL19045930 0.86 IRAK4 (0.75) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988478-B1 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators GENENTECH, INC. (US) 2021-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988478-B1 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators IRAK1, IRAK4, IRAK2 IRAK4 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback